HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh (H1CA34) Stock Price & Analysis

H1CA34 Stock Chart & Stats

R$128.96-R$0.28(-0.22%)

At close: Oct 30

Day’s Range: BRL 128.96 - BRL 130.47
52-Week Range: BRL 90.00 - BRL 150.00
Previous Close: BRL 129.24
Volume: N/A
Average Volume (3M): 152
Market Cap: BRL 537.42B
Enterprise Value: BRL 776.65B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 16324.0
Beta: -0.28
Next Earnings: Feb 02, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: 0.42%

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh News

HCA Healthcare announces proposed public offering of senior notes

HCA Healthcare (HCA) announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity,

8h agoHCA 2BH

HCA Healthcare price target raised to $468 from $381 at Wells Fargo

Wells Fargo raised the firm’s price target on HCA Healthcare (HCA) to $468 from $381 and keeps an Equal Weight rating on the shares. Improvement in core growth was the

11h agoHCA 2BH

HCA Healthcare price target raised to $401 from $387 at Barclays

Barclays analyst Andrew Mok raised the firm’s price target on HCA Healthcare (HCA) to $401 from $387 and keeps an Equal Weight rating on the shares. Published first on TheFly

4d agoHCA 2BH

HCA Healthcare price target raised to $490 from $435 at KeyBanc

KeyBanc analyst Matthew Gillmor raised the firm’s price target on HCA Healthcare (HCA) to $490 from $435 and keeps an Overweight rating on the shares. The firm says Q3 results

5d agoHCA 2BH

HCA Healthcare price target raised to $486 from $460 at TD Cowen

TD Cowen raised the firm’s price target on HCA Healthcare (HCA) to $486 from $460 and keeps a Buy rating on the shares. The firm updated its model following better

5d agoHCA 2BH

HCA Healthcare price target raised to $495 from $475 at Mizuho

Mizuho raised the firm’s price target on HCA Healthcare (HCA) to $495 from $475 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate source

5d agoHCA 2BH

HCA Healthcare price target raised to $409 from $393 at Baird

Baird raised the firm’s price target on HCA Healthcare (HCA) to $409 from $393 and keeps a Neutral rating on the shares. The firm updated its model with a 2027

5d agoHCA 2BH

HCA Healthcare price target raised to $500 from $450 at BofA

BofA raised the firm’s price target on HCA Healthcare (HCA) to $500 from $450 and keeps a Neutral rating on the shares. The company’s Q3 EBITDA came in 5% above

5d agoHCA 2BH

HCA Healthcare sees 2027 earnings ‘generally consistent’ with 2026

Beyond 2027, sees performance more in line with long-term growth targets. Comments taken from Q3 earnings conference call. Published first on TheFly – the ultimate source for real-time, market-moving breaking

6d agoHCA 2BH

HCA Healthcare drop 2.1% to $454.97 after providing guidance on Q3 earnings call

10:13 EDT HCA Healthcare (HCA) drop 2.1% to $454.97 after providing guidance on Q3 earnings call Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.

6d agoHCA 2BH

Guggenheim’s Kevin Fischbeck Reiterates Hold on HCA, Lifts Price Target to $400 Amid Reduced 2026 EBITDA Outlook and Exchange-Market Headwinds

Analyst Kevin Fischbeck of Bank of America Securities reiterated a Hold rating on HCA Healthcare, boosting the price target to $400.00. Kevin Fischbeck has given his Hold rating due to

3M agoHCA 2BH

HCA Healthcare: Buy Rating Reiterated as Margin Stability and Cost Discipline Support Upside, Price Target Maintained at $431

Analyst Ryan Langston from TD Cowen maintained a Buy rating on HCA Healthcare and keeping the price target at $431.00. Ryan Langston has given his Buy rating due to a

3M agoHCA 2BH

H1CA34 FAQ

What was HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s price range in the past 12 months?

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh lowest stock price was R$90.00 and its highest was R$150.00 in the past 12 months.

What is HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s market cap?

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s market cap is R$537.42B.

When is HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s earnings last quarter?

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh released its earnings results on Oct 27, 2026. The company reported R$0.002 earnings per share for the quarter.

Is HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh pay dividends?

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh does not currently pay dividends.

What is HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s EPS estimate?

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh have?

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh has 4,330,030,000 shares outstanding.

What happened to HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s price movement after its last earnings report?

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh reported an EPS of R$0.002 in its last earnings report. Following the earnings report the stock price went down -3.558%.

Which hedge fund is a major shareholder of HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh?

Currently, no hedge funds are holding shares in BR:H1CA34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh (H1CA34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	15	4	3
Technical Analysis	3	4	3
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to BR:H1CA34
Company	Price & Change	Follow
BR:C1AH34Cardinal Health, Inc. Unsponsored Brazilian Depositary Receipt Repr 1 Sh
BR:C1CO34Cencora, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
BR:C1IC34Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh
BR:M1CK34McKesson Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh
BR:MDTC34Medtronic plc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh

Compare BR:H1CA34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

H1CA34 Stock Chart & Stats

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh News

HCA Healthcare announces proposed public offering of senior notes

HCA Healthcare price target raised to $468 from $381 at Wells Fargo

HCA Healthcare price target raised to $401 from $387 at Barclays

HCA Healthcare price target raised to $490 from $435 at KeyBanc

HCA Healthcare price target raised to $486 from $460 at TD Cowen

HCA Healthcare price target raised to $495 from $475 at Mizuho

HCA Healthcare price target raised to $409 from $393 at Baird

HCA Healthcare price target raised to $500 from $450 at BofA

HCA Healthcare sees 2027 earnings ‘generally consistent’ with 2026

HCA Healthcare drop 2.1% to $454.97 after providing guidance on Q3 earnings call

Guggenheim’s Kevin Fischbeck Reiterates Hold on HCA, Lifts Price Target to $400 Amid Reduced 2026 EBITDA Outlook and Exchange-Market Headwinds

HCA Healthcare: Buy Rating Reiterated as Margin Stability and Cost Discipline Support Upside, Price Target Maintained at $431

H1CA34 FAQ

HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh (H1CA34) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium